1.0re.commhttps://recomm.eu/en/Eventhttps://recomm.eu/en/author/event/rich600338<blockquote class="wp-embedded-content" data-secret="KuWEkOiqJN"><a href="https://recomm.eu/en/speaker/ronjon-nag/">Ronjon Nag</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://recomm.eu/en/speaker/ronjon-nag/embed/#?secret=KuWEkOiqJN" width="600" height="338" title="“Ronjon Nag” — re.comm" data-secret="KuWEkOiqJN" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://recomm.eu/wp-includes/js/wp-embed.min.js </script> https://recomm.eu/wp-content/uploads/2026/08/Ronjon.png9081136Prof. Ronjon Nag is an AI pioneer, entrepreneur, and the founder and CEO of Agemica, as well as the founder and president of the R42 Group. As a professor of genetics at Stanford School of Medicine, he has spent many years exploring the intersection of artificial intelligence, biotechnology, and longevity. In his keynote address at re.comm 26, titled “AI, the Aging Vaccine, and the Century Ahead,” Ronjon Nag explores how artificial intelligence could accelerate the development of new vaccine platforms and thereby open up new possibilities in the fight against cancer and age-related diseases. In doing so, he clearly explains how modern AI methods are being used in vaccine development, what scientific and clinical findings are already available, and what regulatory and technological hurdles still need to be overcome. However, his presentation also looks far beyond the field of medicine: a significantly longer human lifespan could fundamentally transform demographics, cities, real estate, pension systems, capital markets, and career paths. Ronjon Nag thus demonstrates how closely technological innovation, social change, and strategic decisions will be intertwined in the future.